Quantitation of human immunodeficiency virus type 2 DNA in peripheral blood mononuclear cells by using a quantitative-competitive PCR assay

Journal of Clinical Microbiology

Volumn 37, Issue 2, 1999, Pages 453-456

  Gomes, Perpétua ^a,b   Taveira, Nuno Costa ^a,b   Moniz Pereira, José ^a   Antunes, Francisco ^c   Santos Ferreira, M O ^a   Lourenço, Maria Helena ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b INSTITUTO SUPERIOR DE CIÊNCIAS DA SAÚDE EGAS MONIZ   (Portugal)

^c HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL ELECTROPHORESIS; GENE AMPLIFICATION; HUMAN IMMUNODEFICIENCY VIRUS; MONONUCLEAR PHAGOCYTE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVIRUS; VIRUS REPLICATION;

EID: 0345683492     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.2.453-456.1999     Document Type: Article

References (24)

1. Ariyoshi, K., N. Berry, A. Wilkins, D. Ricard, P. Aaby, A. Nauclér, P. T. Ngom, O. Jobe, S. Jaffar, F. Dias, R. S. Tedder, and H. Whittle. 1996. A community-based study of human immunodeficiency virus type 2 provirus load in a rural village in West Africa. J. Infect. Dis. 173:245-248.
2. Berry, N., K. Ariyoshi, O. Jobe, P. T. Ngum, T. Corrah, A. Wilkins, H. Whittle, and R. Tedder. 1994. HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4+ lymphopenia in HIV type 2-infected individuals. AIDS Res. Hum. Retroviruses 10:1031-1037.
3. Bjorling, E., G. Scarlatti, A. von Gegerfelt, J. Albert, G. Biberfeld, F. Chiodi, E. Norrby, and E. M. Fenyo. 1993. Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection. Virology 193:528-530.
4. Cavaco-Silva, P., N. C. Taveira, L. Rosado, M. H. Lourenço, J. Moniz-Pereira, N. W. Douglas, R. S. Daniels, and M. O. Santos-Ferreira. 1998. Virological and molecular demonstration of human immunodeficiency virus type 2 vertical transmission. J. Virol. 72:3418-3422.
5. Chun, T.-W., L. Stuyver, S. B. Mizell, L. A. Ehler, J. A. M. Mican, M. Baseler, A. L. Lloyd, M. A. Nowak, and A. S. Fauci. 1997. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 94:13193-13197.
6. Clementi, M., S. Menzo, P. Bagnarelli, A. Valenza, S. Paolucci, R. Sampaolesi, A. Manzin, and P. E. Varaldo. 1996. Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection. Clin. Microhiol. Rev. 9:135-147.
7. + T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J. Virol. 67:1772-1777.
8. Finzi, D., M. Hermankova, T. Pierson, L. M. Carruth, C. Buck, R. E. Chaisson, T. C. Quinn, K. Chadwick, J. Margolick, R. Brookmeyer, J. Gallant, M. Markowitz, D. D. Ho, D. D. Richman, and R. Siciliano. 1997. Identificatiun of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295-1300.
9. Gao, F., L. Yue, D. L. Robertson, S. C. Hill, H. Hui, R. J. Biggar, A. E. Neequaye, T. M. Whelan, D. D. Ho, G. M. Shaw, P. M. Sharp, and B. H. Hahn. 1994. Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J. Virol. 68:7433-7447.
10. Kanki, P. J., and K. M. Cock. 1994. Epidemiology and natural history of HIV-2. AIDS 8:S85-S93.
11. Kanki, P. J., K. U. Travers, S. Mboup, C. C. Hsieh, R. G. Marlink, A. Gueye-Ndiaye, T. Siby, I. Thior, M. Hernandez-Avila, J. L. Sankale, I. Ndoye, and M. E. Essex. 1994. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 343:943-946.
12. Loussert-Ajaka, I., F. Simon, I. Farfara, D. Descamps, G. Collin, and F. Brun-Vézinet. 1995. Detection of circulating human immunodeficiency virus type 2 in plasma by reverse transcription polymerase chain reaction. Res. Virol. 146:409-414.
13. Marlink, R. 1996. Lessons from the second AIDS virus, HIV-2. AIDS 10: 689-699.
14. Marlink, R., P. Kanki, I. Thior, K. Travers, G. Eisen, T. Siby, I. Traore, C. C. Hsieh, M. C. Dia, E. H. Gueye, J. Hellinger, A. Gueye-Ndiaye, J.-L. Sankale, I. M. Ndoye, S. Boup, and M. Essex. 1994. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 265:1587-1590.
15. McKnight, A., M. T. Dittmar, J. Moniz-Pereira, K. Ariyoshi, J. D. Reeves, S. Hibbitls, D. Whitby, E. Aarons, A. E. I. Proudfoot, H. Whittle, and P. R. Clapham. 1998. A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4 J. Virol. 72:4065-4071.
16. Mellors, J. W., C. R. Rinaldo, Jr., P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170.
17. Norrgren, H., S. Marquina, T. Leitner, P. Aaby, M. Melbye, A.-G. Poulsen, O. Larsen, F. Dias, D. Escanilla, S. Andersson, J. Albert, and A. Nauclér. 1997. HIV-2 genetic variation and DNA load in asymptomatic carriers and AIDS cases in Guinea-Bissau. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 16:31-38.
18. O'Brien, W. A., P. M. Hartigan, D. Martin, J. Esinhart, A. Hill, S. Benoit, M. Rubin, M. S. Simberkoff, and J. D. Hamilton. 1996 Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N. Engl. J. Med. 334:426-431.
19. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
20. Santos Ferreira, M. O., C. T. Sakellarides, J. Almeida Gonçalves, and J. L. Castanheira. 1997. Centro de Vigilância Epidemiológica das Doenças Transmissíveis: SIDA, a situaçāo em Portugal em 31 de Dezembro de 1997. Instituto Nacional de Saúde, Lisbon, Portugal.
21. Simon, F., S. Matheron, C. Tamalet, I. Loussert Ajaka, S. Bartczak, J. M. Pepin, C. Dhiver, E. Gamba, C. Elbim, J. A. Gastaut, A. G. Saimot, and F. Brun-Vézinet. 1993. Cellular and plasma viral load in patients infected with HIV-2. AIDS 7:1411-1417.
22. Vesanen, M., C. E. Stevens, P. E. Taylor, P. Rubinstein, and K. Saksela. 1996. Stability in controlling viral replication identifies long-term nonprogressors as a distinct subgroup among human immunodeficiency virus type 1-infected persons. J. Virol. 70:9035-9040.
23. Wong, J. K., H. F. Gunthard, D. V. Havlir, Z.-Q. Zhang, A. T. Haase, C. C. Ignacio, S. Kwok, E. Emini, and D. D. Richman. 1997. Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc. Natl. Acad. Sci. USA 94: 12574-12579.
24. Wong, J. K., M. Hezareh, H. F. Gunthard, D. V. Havlir, C. C. Ignacio, C. A. Spina, and D. D. Richman. 1997. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278:1291-1295.